Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial

Bookmark and Share
Published: 29 May 2015
Views: 1952
Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive Cancer Center, Los Angeles, USA

Dr Anthony El-Khoueiry talks to ecancertv at ASCO 2015 about findings from a phase I/II study that suggest that nivolumab is safe and effective in advanced liver cancer.

Read the news article for more or watch the press conference for more.